Silon Bryan, Siddiqui Ali A, Taylor Linda Jo, Arastu Sanaa, Soomro Ammara, Adler Douglas G
Gastroenterology and Hepatology, Huntsman Cancer Center, University of Utah School of Medicine, 30N 1900E 4R118, Salt Lake City, UT, 84132, USA.
Gastroenterology and Hepatology, Jefferson University School of Medicine, Philadelphia, PA, USA.
Dig Dis Sci. 2017 Feb;62(2):424-431. doi: 10.1007/s10620-016-4390-0. Epub 2016 Dec 23.
Esophagorespiratory fistulas (ERF) are a devastating complication of benign and malignant etiologies. ERF are associated with high mortality, short survival, and poor quality of life. We performed a multicenter analysis of patients with ERF undergoing endoscopic treatment.
Multicentre retrospective study.
We analyzed 25 patients undergoing 35 procedures over an 8-year period. Our data showed high technical success rates (97.1% of procedures) and with good, but not ideal, clinical success rates (60% of procedures, 80% of patients), which were defined as fistula closure confirmed by radiographic or repeat endoscopic evaluation and/or a lack of recurrent episodes of clinical aspiration to focus on durable ERF closure as opposed to only initial success. Proximal ERF were the most difficult to manage with the lowest overall clinical success rates, highest rates of recurrent aspiration despite endoscopic therapy, highest adverse events, and shortest survival times. Adverse events occurred in 40.0% of our patients and were all minor. Treatment allowed for diet advancement in 75% of patients.
This represents the largest recent collection of US data and the first multicenter study evaluating the clinical success of multiple treatment modalities while stratifying data by fistula etiology and esophageal location. The endoscopic approaches detailed in this study offer a minimally invasive and safe choice for intervention with the potential to improve quality of life despite overall suboptimal clinical success and survivorship rates for in with ERF.
食管气管瘘(ERF)是良性和恶性病因导致的一种严重并发症。ERF与高死亡率、短生存期及生活质量差相关。我们对接受内镜治疗的ERF患者进行了多中心分析。
多中心回顾性研究。
我们分析了8年间接受35例手术的25例患者。我们的数据显示技术成功率高(97.1%的手术),临床成功率良好但不理想(60%的手术,80%的患者),临床成功率定义为经影像学或重复内镜评估确认瘘口闭合和/或无反复临床误吸发作,重点是实现持久的ERF闭合而非仅初始成功。近端ERF最难处理,总体临床成功率最低,内镜治疗后反复误吸发生率最高,不良事件发生率最高,生存期最短。40.0%的患者发生不良事件,均为轻微不良事件。75%的患者经治疗后可恢复正常饮食。
这是近期美国最大规模的数据收集,也是第一项多中心研究,评估了多种治疗方式的临床成功率,同时按瘘病因和食管位置对数据进行分层。本研究详细介绍的内镜治疗方法为干预提供了一种微创且安全的选择,尽管ERF的总体临床成功率和生存率不理想,但仍有可能改善生活质量。